Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
Intranasal Spray (Experimental): As discussed, an intranasal form of PT-141 was used in research trials with higher doses (e.g
Novo Nordisks semaglutide, the GLP-1 analog used in Ozempic and Wegovy, showed an average weight loss of 10.6% at 68 weeks with the 2.4 mg dose in adults with type 2 diabetes and obesity or overweight in the STEP 2 Phase 3 trial
This is designed to last 12 weeks using the standard starting schedule of: 2.5 mg weekly for 4 weeks, 5 mg weekly for 4 weeks, and 7.5 mg weekly for 4 weeks
Contrave is designed as part of a comprehensive weight management program that includes a reduced-calorie diet and increased physical activity
&srotate=0)
US$ 27.15
US$ 22.31
US$ 23.18
US$ 25.51
US$ 24.46
US$ 21.73
